Bronchoalveolar lavage and transbronchial lung biopsy during acute rejection and infection in heart-lung transplant patients. Studies of cell counts, lymphocyte phenotypes, and expression of HLA-DR and interleukin-2 receptor.
The total and differential cell counts of 135 bronchoalveolar lavages (BAL) in 48 heart-lung transplant (HLT) patients were compared with the histologic findings in concurrent transbronchial lung biopsies (TBBs). Counts of CD3+, CD4+, and CD8+ lymphocytes were recorded, and a semiquantitative assessment of HLA-DR and interleukin-2 receptor (IL-2R) expression was made on 29 occasions. There were five diagnostic categories: normal (n = 8), acute rejection (ALR) (n = 57), treated rejection (TR) (n = 19), infection (INF) (n = 24), and chronic rejection (CR) (n = 24). Total cell counts in INF were significantly higher than counts in all the other diagnostic groups. The highest BAL lymphocyte counts, significantly higher than in INF, were found in ALR because of increased CD8+ cells, exceeding 15% in 13 of 57 BALs. TBBs in ALR by contrast showed significantly increased numbers of both CD8+ and CD4+ cells. High dose corticosteroid treatment of ALR caused a fall in cellularity of BAL and TBB specimens but not always to values seen when patients were well. During INF and CR, significantly increased numbers of PMNs were seen in the BAL. HLA-DR and IL-2R expression was enhanced in cells of BAL and TBB in all complications. BAL can only supplement at present histologic examination of TBB in the diagnosis of complications after HLT.
Clelland
C
C
Papworth Hospital, Department of Pathology, Cambridge, United Kingdom.
Higenbottam
T
T
Stewart
S
S
Otulana
B
B
Wreghitt
T
T
Gray
J
J
Scott
J
J
Wallwork
J
J
D000208:Acute Disease; D001706:Biopsy; D001992:Bronchoalveolar Lavage Fluid / Q000382:microbiology / Q000473:pathology*; D001999:Bronchoscopy; D006084:Graft Rejection / Q000175:diagnosis / Q000276:immunology / Q000473:pathology*; D006684:HLA-DR Antigens / Q000032:analysis*; D016041:Heart-Lung Transplantation / Q000009:adverse effects / Q000276:immunology / Q000473:pathology*; D006801:Humans; D016130:Immunophenotyping; D007958:Leukocyte Count; D008168:Lung / Q000382:microbiology / Q000473:pathology*; D008214:Lymphocytes / Q000276:immunology / Q000473:pathology*; D011446:Prospective Studies; D015375:Receptors, Interleukin-2 / Q000032:analysis*; D013530:Surgical Wound Infection / Q000175:diagnosis / Q000276:immunology / Q000473:pathology*
D006684:HLA-DR Antigens; D015375:Receptors, Interleukin-2